DK0941100T3 - Farmaceutiske præparater indeholdende lamivudin og zidovudin - Google Patents

Farmaceutiske præparater indeholdende lamivudin og zidovudin

Info

Publication number
DK0941100T3
DK0941100T3 DK97950036T DK97950036T DK0941100T3 DK 0941100 T3 DK0941100 T3 DK 0941100T3 DK 97950036 T DK97950036 T DK 97950036T DK 97950036 T DK97950036 T DK 97950036T DK 0941100 T3 DK0941100 T3 DK 0941100T3
Authority
DK
Denmark
Prior art keywords
zidovudine
pharmaceuticals containing
containing lamivudine
lamivudine
pharmaceuticals
Prior art date
Application number
DK97950036T
Other languages
Danish (da)
English (en)
Inventor
Wayne Goodson Gary
Wayne Wood Allen
Katherine Jeannette Ford
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0941100T3 publication Critical patent/DK0941100T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK97950036T 1996-10-31 1997-10-29 Farmaceutiske præparater indeholdende lamivudin og zidovudin DK0941100T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions
PCT/EP1997/005953 WO1998018477A2 (en) 1996-10-31 1997-10-29 Pharmaceutical compositions containing lamivudine and zidovudine

Publications (1)

Publication Number Publication Date
DK0941100T3 true DK0941100T3 (da) 2003-09-01

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97950036T DK0941100T3 (da) 1996-10-31 1997-10-29 Farmaceutiske præparater indeholdende lamivudin og zidovudin

Country Status (43)

Country Link
EP (1) EP0941100B1 (pl)
JP (1) JP2001502718A (pl)
KR (1) KR100551652B1 (pl)
AP (1) AP1067A (pl)
AR (1) AR009135A1 (pl)
AT (1) ATE241364T1 (pl)
AU (1) AU736607B2 (pl)
BG (1) BG64541B1 (pl)
BR (1) BR9712614A (pl)
CA (1) CA2270174A1 (pl)
CO (1) CO4930269A1 (pl)
CY (1) CY2485B1 (pl)
CZ (1) CZ296080B6 (pl)
DE (1) DE69722433T2 (pl)
DK (1) DK0941100T3 (pl)
EA (1) EA002437B1 (pl)
EE (1) EE03806B1 (pl)
ES (1) ES2200204T3 (pl)
GB (1) GB9622681D0 (pl)
GE (1) GEP20022735B (pl)
GT (1) GT199700116A (pl)
HR (1) HRP970569B1 (pl)
HU (1) HU224969B1 (pl)
ID (1) ID18698A (pl)
IL (1) IL129422A0 (pl)
IS (1) IS5024A (pl)
MY (1) MY119513A (pl)
NO (1) NO317163B1 (pl)
NZ (1) NZ335153A (pl)
OA (1) OA11038A (pl)
PA (1) PA8441101A1 (pl)
PE (1) PE10099A1 (pl)
PL (1) PL190349B1 (pl)
PT (1) PT941100E (pl)
SI (1) SI0941100T1 (pl)
SK (1) SK284286B6 (pl)
SV (1) SV1997000090A (pl)
TR (1) TR199900950T2 (pl)
UA (1) UA64725C2 (pl)
UY (1) UY24766A1 (pl)
WO (1) WO1998018477A2 (pl)
YU (1) YU19999A (pl)
ZA (1) ZA979726B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
DE60219965T2 (de) * 2002-04-23 2008-01-17 Lupin Ltd., Mumbai Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
AU2003291457A1 (en) * 2002-11-08 2004-06-03 Glaxo Group Limited Pharmaceutical antiviral compositions
EA015145B1 (ru) 2003-01-14 2011-06-30 Джилид Сайэнс, Инк. Фармацевтическая композиция и пероральная фармацевтическая дозированная форма (варианты), проявляющие активность в отношении вич-инфекций, лечебный набор и таблетка и способ лечения или предотвращения симптомов или эффектов вич-инфекции
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
CN104203275A (zh) 2010-06-09 2014-12-10 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
IN2014MN01907A (pl) 2012-03-05 2015-07-10 Cipla Ltd
EP2958563A2 (en) * 2013-02-20 2015-12-30 AbbVie Inc. Tablet dosage form comprising ritonavir and lopinavir
JP2023010676A (ja) * 2021-07-09 2023-01-20 株式会社東洋新薬 固形組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
DE69206876T3 (de) * 1991-05-16 2004-08-12 Glaxo Group Ltd., Greenford Nukleosidanalogen enthaltende Antiviren-Zubereitungen
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
PL190349B1 (pl) 2005-11-30
SV1997000090A (es) 1998-10-07
OA11038A (en) 2002-02-06
NO317163B1 (no) 2004-08-30
HUP0000344A2 (hu) 2001-05-28
ID18698A (id) 1998-04-30
EE9900175A (et) 1999-12-15
GB9622681D0 (en) 1997-01-08
EE03806B1 (et) 2002-08-15
MY119513A (en) 2005-06-30
NO992091D0 (no) 1999-04-29
EA199900345A1 (ru) 2000-02-28
AP1067A (en) 2002-05-01
HRP970569B1 (en) 2004-10-31
HU224969B1 (en) 2006-04-28
GT199700116A (es) 1999-04-22
KR100551652B1 (ko) 2006-02-13
SI0941100T1 (en) 2003-12-31
CZ155799A3 (cs) 1999-10-13
AR009135A1 (es) 2000-03-08
CY2485B1 (en) 2005-06-03
AP9901519A0 (en) 1999-06-30
WO1998018477A2 (en) 1998-05-07
HK1020880A1 (en) 2000-05-26
HRP970569A2 (en) 1998-08-31
BG64541B1 (bg) 2005-07-29
BR9712614A (pt) 1999-10-26
ZA979726B (en) 1999-04-29
JP2001502718A (ja) 2001-02-27
PT941100E (pt) 2003-10-31
GEP20022735B (en) 2002-07-25
CA2270174A1 (en) 1998-05-07
UY24766A1 (es) 2000-12-29
IS5024A (is) 1999-04-09
NZ335153A (en) 2001-04-27
EA002437B1 (ru) 2002-04-25
DE69722433D1 (de) 2003-07-03
ATE241364T1 (de) 2003-06-15
YU19999A (sh) 2000-10-30
PL333143A1 (en) 1999-11-22
BG103435A (en) 2000-04-28
IL129422A0 (en) 2000-02-17
PA8441101A1 (es) 2000-05-24
TR199900950T2 (xx) 1999-07-21
KR20000052893A (ko) 2000-08-25
NO992091L (no) 1999-06-29
AU736607B2 (en) 2001-08-02
ES2200204T3 (es) 2004-03-01
HUP0000344A3 (en) 2002-04-29
SK57599A3 (en) 2000-06-12
WO1998018477A3 (en) 1998-06-18
EP0941100B1 (en) 2003-05-28
DE69722433T2 (de) 2004-04-08
CZ296080B6 (cs) 2006-01-11
EP0941100A2 (en) 1999-09-15
CO4930269A1 (es) 2000-06-27
PE10099A1 (es) 1999-03-02
AU5314298A (en) 1998-05-22
SK284286B6 (sk) 2005-01-03
UA64725C2 (uk) 2004-03-15

Similar Documents

Publication Publication Date Title
NO980255L (no) Antiparasittiske marcfortiner og paraherkvamider
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO943763D0 (no) 4-arylamino-benzopyraner og beslektede forbindelser
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
DE59503153D1 (de) Ringbuchmechanik
DE59707845D1 (de) Kryostatmikrotom
DE69625078D1 (de) Analysator
NO20000682D0 (no) Pakning og dispenser
KR960016892A (ko) 약제의 신독성 경감제
NO954880D0 (no) Cytidin deaminase
DE69825615D1 (de) Gaseinführung
DE69617715D1 (de) Materialanalyse
NO992091D0 (no) Farmas°ytiske blandinger inneholdende lamivudin og zidovudin
DK0671119T3 (da) Stavvalse
KR960010685A (ko) 펩티드 및 그 용도
FI952772L (fi) Uusia fenyylietyyli- ja fenyylipropyyliamiineja
NO983346D0 (no) Tamoxifen og analoger derav
DE69703327D1 (de) Schaubehälter
KR960002831U (ko) 기 게양대
DE4498382D2 (de) Eisstock
KR960000238U (ko) 휴대용 케이스
KR960026553U (ko) 크레파스 케이스
BR9301839A (pt) Ticket gas
NO940574D0 (no) Fortilsats og for inneholdende denne
KR960002595U (ko) 대공 사격용 가늠자와 가늠쇠